GlassScriptPhysician profile
Ayla A Gregg
NPI 1447601810
$232.21
in general payments reported to CMS, 2019-2025
9 companies · $51.93 in 2025
The $51.93 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $34.07 · 2024: $146 · 2025: $51.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $232.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $92.80 | 2024 | Edarbi |
| Resmed Corp | $22.67 | 2025 | |
| Exact Sciences Corporation | $22.31 | 2024 | Cologuard Collection Kit |
| Lexicon Pharmaceuticals, INC. | $21.28 | 2023 | Inpefa |
| Organon LLC | $17.52 | 2024 | |
| Novo Nordisk INC | $15.65 | 2025 | |
| Phathom Pharmaceuticals, INC. | $13.61 | 2025 | Voquezna |
| Janssen Pharmaceuticals, INC | $13.58 | 2024 | Invega Sustenna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.79 | 2023 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayla Gregg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.